Zydus Cadila Gets DGCI Nod for Phase 3 Covid Vaccine Clinical Trials with Biological Therapy
Team Udayavani, Dec 4, 2020, 1:39 PM IST
Drug firm Zydus Cadila on Friday said it has received the approval fromthe Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients. The company had completed the phase 2 clinical trials with PegiHep last month.
In a regulatory filing, Zydus Cadila said it has received approval from the DCGI to start the phase 3 clinical trials in COVID-19 patients with its biological therapy Pegylated Interferon alpha-2b or PegiHep. The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.
Sharvil Patel, Managing Director of Cadila Healthcare Ltd, said, “we are encouraged by the results of phase 2 study of Pegylated Interferon alpha 2-b which has shown the potential to reduce virus titres when given earlier in the disease. “Our efforts are to look at possible treatment options to fight COVID-19 which are safe, can be administered easily and also reduce the disease burden”.
Further, the company said it is conducting a similar phase 2 trial in Mexico and is also working withthe US Food and Drug Administration (USFDA) toopen an Investigational New Drug (IND) application for PegiHep in order to initiate appropriate clinical trials in the US.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
‘Idiot’: Former Canadian Sikh minister slams Justin Trudeau over Khalistan issue
Canadian cop suspended for attending pro-Khalistan protest outside Hindu temple
US going to historically tight presidential election
Expect Canadian government to ensure justice, uphold rule of law: PM Modi
Khalistanis clash with people at Hindu temple in Canada, Trudeau says unacceptable
MUST WATCH
Latest Additions
Like UP, bring BJP to power in Jharkhand to ‘bulldoze’ mafia: Yogi at Koderma poll rally
Govt asks Wikipedia why it should not be treated as publisher instead of intermediary
MUDA Case: K’taka HC adjourns hearing to November 26
SC upholds validity of UP madrassa law, says it does not violate principle of secularism
Union Minister H D Kumaraswamy booked for threatening police officer
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.